Koç University School of Medicine, Division of Pediatric Endocrinology and Diabetes, Turkey.
Gazi University, School of Medicine, Division of Pediatric Endocrinology and Diabetes, Turkey.
Diabet Med. 2019 Oct;36(10):1243-1250. doi: 10.1111/dme.14038. Epub 2019 Jul 4.
To describe the baseline clinical and laboratory findings and treatment modalities of 367 children and adolescents diagnosed with Type 2 diabetes in various paediatric endocrinology centres in Turkey.
A standard questionnaire regarding clinical and laboratory characteristics at onset was uploaded to an online national database system. Data for 367 children (aged 6-18 years) newly diagnosed with Type 2 diabetes at 37 different paediatric endocrinology centres were analysed.
After exclusion of the children with a BMI Z-score < 1 SD, those with genetic syndromes associated with Type 2 diabetes, and those whose C-peptide and/or insulin levels were not available, 227 cases were included in the study. Mean age was 13.8 ± 2.2 (range 6.5-17.8) years, with female preponderance (68%). Family history of Type 2 diabetes was positive in 86% of the children. The mean BMI was 31.3 ± 6.5 kg/m (range 18.7-61) and BMI Z-score was 2.4 ± 0.8 (range 1-5). More than half (57%) of the children were identified by an opportunistic diabetes screening due to existing risk markers without typical symptoms of diabetes. Only 13% (n = 29) were treated solely by lifestyle modification, while 40.5% (n = 92) were treated with metformin, 13% (n = 30) were treated with insulin, and 33.5% (n = 76) were treated with a combination of insulin and metformin initially. Mean HbA levels of the insulin and combination of insulin and metformin groups were 98 (11.1%) and 102 mmol/mol (11.5%), respectively, and also were significantly higher than the lifestyle modification only and metformin groups mean HbA levels (70(8.6%) and 67 mmol/mol (8.3%), respectively).
An opportunistic screening of children who are at high risk of Type 2 diabetes is essential, as our data showed that > 50% of the children were asymptomatic at diagnosis. The other important result of our study was the high rate of exclusion from the initial registration (38%), suggesting that accurate diagnosis of Type 2 diabetes in youth is still problematic, even for paediatric endocrinologists.
描述 367 名在土耳其不同儿科内分泌中心被诊断为 2 型糖尿病的儿童和青少年的基线临床和实验室检查结果及治疗方式。
将一份关于发病时临床和实验室特征的标准问卷上传到一个在线国家数据库系统。对 37 个不同儿科内分泌中心新诊断为 2 型糖尿病的 367 名儿童(年龄 6-18 岁)的数据进行了分析。
排除 BMI Z 评分<1SD、与 2 型糖尿病相关的遗传综合征以及无法获得 C 肽和/或胰岛素水平的儿童后,本研究纳入了 227 例病例。平均年龄为 13.8 ± 2.2(范围 6.5-17.8)岁,女性居多(68%)。86%的儿童有 2 型糖尿病家族史。平均 BMI 为 31.3 ± 6.5kg/m(范围 18.7-61),BMI Z 评分 2.4 ± 0.8(范围 1-5)。由于存在潜在的风险标志物,超过一半(57%)的儿童通过机会性糖尿病筛查发现,而没有典型的糖尿病症状。只有 13%(n=29)仅通过生活方式改变进行治疗,而 40.5%(n=92)使用二甲双胍治疗,13%(n=30)使用胰岛素治疗,33.5%(n=76)初始联合胰岛素和二甲双胍治疗。胰岛素和胰岛素联合二甲双胍组的平均 HbA1c 水平分别为 98mmol/mol(11.1%)和 102mmol/mol(11.5%),也显著高于仅生活方式改变和二甲双胍组的平均 HbA1c 水平(分别为 70mmol/mol(8.6%)和 67mmol/mol(8.3%))。
对有 2 型糖尿病高危风险的儿童进行机会性筛查非常重要,因为我们的数据显示,>50%的儿童在诊断时无症状。我们研究的另一个重要结果是初始登记的排除率很高(38%),这表明即使是儿科内分泌医生,青少年 2 型糖尿病的准确诊断仍存在问题。